The Global Deterioration Scale for Down Syndrome Population (GDS-DS): A Rating Scale to Assess the Progression of Alzheimer's Disease.

Adult Humans Alzheimer Disease / epidemiology Down Syndrome / epidemiology Cohort Studies Reproducibility of Results Retrospective Studies Disease Progression
Alzheimer’s disease cognitive decline cognitive testing dementia down syndrome global deterioration scale intellectual disability rating scale

Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
14 03 2023
Historique:
received: 29 12 2022
revised: 09 03 2023
accepted: 13 03 2023
medline: 30 3 2023
entrez: 29 3 2023
pubmed: 30 3 2023
Statut: epublish

Résumé

The aim of this study is to adapt and validate the global deterioration scale (GDS) for the systematic tracking of Alzheimer's disease (AD) progression in a population with Down syndrome (DS). A retrospective dual-center cohort study was conducted with 83 participants with DS (46.65 ± 5.08 years) who formed the primary diagnosis (PD) group: cognitive stability (

Identifiants

DOI: 10.3390/ijerph20065096 PMID: 36982004 PMC: PMC10049652
pubmed: 36982004
pii: ijerph20065096
doi: 10.3390/ijerph20065096
pmc: PMC10049652
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Alzheimers Dement (Amst). 2021 Mar 17;13(1):e12164
pubmed: 33748395
Int J Geriatr Psychiatry. 2020 Jun;35(6):650-661
pubmed: 32100307
Curr Alzheimer Res. 2016;13(1):18-29
pubmed: 26651341
JAMA Neurol. 2020 Feb 1;77(2):262-264
pubmed: 31657825
Lancet Neurol. 2014 Jun;13(6):614-29
pubmed: 24849862
Dementia. 1995 Jul-Aug;6(4):205-10
pubmed: 7550600
Alzheimers Dement (Amst). 2016 Jun 30;4:126-148
pubmed: 27752536
Neurobiol Aging. 2019 Dec;84:70-79
pubmed: 31518951
Am J Psychiatry. 1982 Sep;139(9):1136-9
pubmed: 7114305
Alzheimers Dement. 2019 Feb;15(2):245-257
pubmed: 30503169
Brain Connect. 2021 Nov;11(9):725-733
pubmed: 33858203
Curr Alzheimer Res. 2010 Jun;7(4):280-6
pubmed: 19715548
Alzheimers Dement. 2018 Apr;14(4):535-562
pubmed: 29653606
Int J Geriatr Psychiatry. 2015 Aug;30(8):857-63
pubmed: 25363568
Alzheimers Dement (Amst). 2020 Jul 05;12(1):e12044
pubmed: 32647741
Actas Luso Esp Neurol Psiquiatr Cienc Afines. 1979 May-Jun;7(3):189-202
pubmed: 474231
Neurology. 2022 Oct 25;99(17):e1866-e1874
pubmed: 36028322
J Neurodev Disord. 2020 Jan 23;12(1):4
pubmed: 31973697
JAMA Netw Open. 2022 Aug 1;5(8):e2225573
pubmed: 35930282
Alzheimers Res Ther. 2022 Sep 3;14(1):123
pubmed: 36057615
Lancet Neurol. 2021 Jun;20(6):484-496
pubmed: 33933186
Neuroimage Clin. 2018 Jan 28;18:160-166
pubmed: 29868444
Rev Neurol. 2017 May 16;64(10):433-444
pubmed: 28497439
Alzheimers Dement. 2020 Dec;16(12):1745-1749
pubmed: 33140565
Soc Psychiatry Psychiatr Epidemiol. 1997 Aug;32(6):344-54
pubmed: 9299929
Alzheimers Dement. 2016 Feb;12(2):195-202
pubmed: 26096665
Sci Rep. 2021 Mar 11;11(1):5736
pubmed: 33707583
J Appl Res Intellect Disabil. 2021 May;34(3):905-915
pubmed: 33314467
Molecules. 2022 May 19;27(10):
pubmed: 35630721
Neurology. 2022 May 24;98(21):e2132-e2139
pubmed: 35351783
J Alzheimers Dis. 2017;57(1):61-70
pubmed: 28222523
Alzheimers Dement (N Y). 2018 Dec 13;4:703-713
pubmed: 30581976
Alzheimers Dement (Amst). 2020 Jun 28;12(1):e12047
pubmed: 32613076
Psychopharmacol Bull. 1988;24(4):653-9
pubmed: 3249767
Neurobiol Aging. 2017 Aug;56:41-49
pubmed: 28482213
Ann Clin Transl Neurol. 2018 May 20;5(6):741-751
pubmed: 29928657
Intellect Dev Disabil. 2017 Oct;55(5):338-346
pubmed: 28972868
J Alzheimers Dis. 2013;33(2):473-81
pubmed: 22986775
Brain Sci. 2020 Nov 12;10(11):
pubmed: 33198271
Nat Rev Neurol. 2019 Mar;15(3):135-147
pubmed: 30733618
J Appl Res Intellect Disabil. 2021 Nov;34(6):1602-1617
pubmed: 34212466
Alzheimers Dement (Amst). 2022 Oct 03;14(1):e12361
pubmed: 36212742
Brain. 2018 Aug 1;141(8):2457-2474
pubmed: 29945247
Brain Imaging Behav. 2019 Feb;13(1):154-161
pubmed: 29644521
J Alzheimers Dis. 2018;61(2):717-728
pubmed: 29226868
Am J Intellect Dev Disabil. 2015 Nov;120(6):481-9
pubmed: 26505869
Am J Med Genet A. 2013 Apr;161A(4):642-9
pubmed: 23436430
Alzheimers Dement (Amst). 2020 Oct 27;12(1):e12062
pubmed: 33134477
Span J Psychol. 2017 Jul 20;20:E32
pubmed: 28726593
Alzheimers Res Ther. 2010 Aug 26;2(4):24
pubmed: 20796301
Curr Alzheimer Res. 2022;19(6):407-419
pubmed: 35929623
J Intellect Disabil Res. 2002 Mar;46(Pt 3):198-208
pubmed: 11896805
J Appl Res Intellect Disabil. 2022 Mar;35(2):495-505
pubmed: 34693611
J Neurodev Disord. 2019 Dec 16;11(1):39
pubmed: 31842726
Child Neuropsychol. 2000 Sep;6(3):235-8
pubmed: 11419452
Int J Geriatr Psychiatry. 2017 Sep;32(9):977-982
pubmed: 27464599
J Neurodev Disord. 2021 Apr 20;13(1):17
pubmed: 33879062
Dev Disabil Res Rev. 2013;18(1):31-42
pubmed: 23949827
Neurology. 1993 Nov;43(11):2412-4
pubmed: 8232972
J Appl Res Intellect Disabil. 2021 Nov;34(6):1618-1629
pubmed: 34196460
Front Aging Neurosci. 2022 Oct 20;14:988540
pubmed: 36337705
Br J Clin Psychol. 2008 Mar;47(Pt 1):1-29
pubmed: 17681112
Rev Neurol. 2013 Oct 16;57(8):337-46
pubmed: 24081888
JAMA Neurol. 2019 Feb 1;76(2):152-160
pubmed: 30452522
Alzheimers Dement. 2021 Apr;17(4):595-604
pubmed: 33226718
Brain. 2008 Nov;131(Pt 11):2957-68
pubmed: 18829698

Auteurs

Emili Rodríguez-Hidalgo (E)

Specialized Service in Mental Health and Intellectual Disability, Institute of Health Assistance (IAS), Parc Hospitalari Martí i Julià, 17190 Girona, Spain.
Neurodevelopmental Group [Girona Biomedical Research Institute]-IDIBGI, Institute of Health Assistance (IAS), Parc Hospitalari Martí i Julià, 17190 Girona, Spain.
ORCID: 0000-0002-6415-3722

Javier García-Alba (J)

Research and Psychology in Education Department, Complutense University of Madrid, 28040 Madrid, Spain.
ORCID: 0000-0002-3342-6572

Ramon Novell (R)

Specialized Service in Mental Health and Intellectual Disability, Institute of Health Assistance (IAS), Parc Hospitalari Martí i Julià, 17190 Girona, Spain.
Neurodevelopmental Group [Girona Biomedical Research Institute]-IDIBGI, Institute of Health Assistance (IAS), Parc Hospitalari Martí i Julià, 17190 Girona, Spain.

Susanna Esteba-Castillo (S)

Specialized Service in Mental Health and Intellectual Disability, Institute of Health Assistance (IAS), Parc Hospitalari Martí i Julià, 17190 Girona, Spain.
Neurodevelopmental Group [Girona Biomedical Research Institute]-IDIBGI, Institute of Health Assistance (IAS), Parc Hospitalari Martí i Julià, 17190 Girona, Spain.
ORCID: 0000-0003-0414-0599

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › The Global Deterioration Scale for Down...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › The Global Deterioration Scale for Down...
questionsmedicales.fr › Troubles mentaux › Troubles neurocognitifs › Démence › Maladie d'Alzheimer › The Global Deterioration Scale for Down...
questionsmedicales.fr › Malformations et maladies congénitales, héréditaires et néonatales › Maladies génétiques congénitales › Maladies chromosomiques › Syndrome de Down › The Global Deterioration Scale for Down...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › The Global Deterioration Scale for Down...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Méthodologie en recherche épidémiologique › Reproductibilité des résultats › The Global Deterioration Scale for Down...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Études rétrospectives › The Global Deterioration Scale for Down...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Caractéristiques de la maladie › Évolution de la maladie › The Global Deterioration Scale for Down...